US
Europe

 

US
Europe

 

missionhistorymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

 

Deutsch

 

enlarged text

 

 

  BOARD OF DIRECTORS

Axel Bolte
Investment Advisor, HBM Partners

Thomas Dyrberg, M.D., Ph.D.
Partner, Novo A/S

Lutz Giebel, Ph.D.
Managing Partner, SV Life Sciences

David R. Guyer, M.D.
Venture Partner, SV Life Sciences
 
David Schnell, M.D.
Managing Director, Prospect Venture Partners

Ulrich Grau, Ph.D.
President & CEO

 

© 2008 Lux Biosciences, Inc. All rights reserved.             Web Terms

LX201LX211LX212LX214polymer technologypipeline
other projects

uveitiscorneal transplantationdry eye syndromeage-related macular degeneration

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us